{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Kimia Biosciences Ltd
Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend
Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year.
Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend
Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.
Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend
Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.
Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend
Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices.
Why is Kimia Bioscien. falling/rising?
On 21-Nov, Kimia Biosciences Ltd witnessed a significant decline in its share price, falling by 5.78% to close at ₹32.13. This drop reflects ongoing concerns about the company's weak long-term fundamentals, high debt levels, and underwhelming recent financial performance, which have collectively weighed on investor sentiment.
Kimia Biosciences Q2 FY26: Margin Compression Overshadows Revenue Growth
Kimia Biosciences Ltd., a Gurgaon-based pharmaceutical company specialising in bulk drug manufacturing, reported net profit of ₹1.02 crores for Q2 FY26, marking a sequential increase of 70.00% from ₹0.60 crores in Q1 FY26. However, year-on-year comparison reveals a concerning decline of 36.65% from ₹1.61 crores in Q2 FY25. The company's stock, trading at ₹34.00 with a modest market capitalisation of ₹159 crores, has struggled significantly, declining 27.66% over the past year whilst the broader Sensex gained 9.48%.
Kimia Biosciences Financial Trend Shifts to Flat Amid Mixed Quarterly Performance
Kimia Biosciences, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable adjustment in its financial trend parameter, moving from a negative to a flat evaluation in the quarter ending September 2025. This shift reflects a stabilisation in key financial metrics despite ongoing challenges in profitability and margin performance.
Is Kimia Bioscien. overvalued or undervalued?
As of November 17, 2025, Kimia Bioscien. is considered an attractive investment opportunity due to its undervaluation compared to peers, with a PE Ratio of 19.11, a low PEG Ratio of 0.11, and strong ROE of 82.13%, despite a year-to-date stock performance of -27.62%.
How has been the historical performance of Kimia Bioscien.?
Kimia Bioscien's historical performance has shown fluctuations, with net sales declining from a peak of 132.71 Cr in Mar'21 to 118.92 Cr in Mar'25. However, the latest fiscal year marked a recovery, with operating profit rising to 21.57 Cr and profit after tax reaching 9.61 Cr, alongside an increase in total assets.
How has been the historical performance of Kimia Bioscien.?
Kimia Bioscien has shown a fluctuating financial performance, with net sales declining from 132.71 Cr in March 2021 to 118.92 Cr in March 2025, but recovering in profitability with a profit after tax of 9.61 Cr in March 2025, reversing previous losses. The company also improved its cash flow from operating activities to 21.00 Cr in the latest fiscal year.
Why is Kimia Bioscien. falling/rising?
As of 14-Nov, Kimia Biosciences Ltd's stock price has risen to Rs 34.98, reflecting a 9.31% increase, with strong short-term performance despite long-term challenges. The stock's recent profit growth and increased investor participation indicate a potential positive shift in sentiment, despite high debt levels.
Is Kimia Bioscien. overvalued or undervalued?
As of November 13, 2025, Kimia Bioscien. is fairly valued with a PE ratio of 17.26 and an EV to EBITDA ratio of 9.63, but has underperformed in the market with a year-to-date return of -29.9%, despite having a strong ROE of 88.05% compared to its peers.
When is the next results date for Kimia Bioscien.?
Kimia Bioscien. will announce its results on 14 November 2025.
Kimia Biosciences Hits New 52-Week Low at Rs. 29.11
Kimia Biosciences has hit a new 52-week low, reflecting ongoing struggles for the microcap pharmaceutical company. Recent performance metrics show significant declines in net sales and profits, alongside a negative annual return. The stock is trading below key moving averages, indicating a sustained downward trend amid high debt levels.
Kimia Biosciences Stock Hits 52-Week Low at Rs. 30.6
Kimia Biosciences has hit a new 52-week low of Rs. 30.6, reflecting a significant decline in its stock performance with a one-year return of -32.69%. Despite this, the stock showed some resilience, outperforming its sector. Financial metrics indicate challenges, including a notable drop in net sales and profit after tax.
Kimia Biosciences Stock Plummets to New 52-Week Low at Rs. 30.6
Kimia Biosciences has hit a new 52-week low at Rs. 30.6, reflecting a downturn amid a broader market decline. Despite this, the company showed some resilience, outperforming its sector today. Over the past year, it has experienced a notable decline in performance, contrasting with the Sensex's gains.
Why is Kimia Bioscien. falling/rising?
As of 06-Nov, Kimia Biosciences Ltd's stock price is Rs 31.08, down 1.86%, and has fallen for two consecutive days, indicating a bearish trend. The stock is underperforming compared to the market, with significant declines over the past month and year-to-date, alongside reduced investor confidence.
Why is Kimia Bioscien. falling/rising?
As of 28-Oct, Kimia Biosciences Ltd's stock price is Rs. 32.99, down 2.37%, and has reached a 52-week low of Rs. 30.62. The stock has significantly underperformed the market, with a year-to-date decline of 27.73% compared to the Sensex's gain of 8.30%.
Kimia Biosciences Hits New 52-Week Low at Rs. 30.62
Kimia Biosciences has hit a new 52-week low, reflecting ongoing struggles for the microcap pharmaceutical company. Over the past year, it has seen a significant decline in stock performance and profitability, with net sales and profit after tax both decreasing sharply, compounded by high debt levels.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
